DFP is used as a clinical therapy worldwide in thalassemia and other non-iron-loading disorders, such as Friedreich’s ataxia [65], pantothenic kinase-associated neurodegeneration [66], Parkinson’s disease [67] and other similar cases. The gene discussed is PANK1; the disease is Parkinson disease.